AURA
Price
$6.73
Change
+$0.18 (+2.75%)
Updated
Aug 8, 01:51 PM (EDT)
Capitalization
406.13M
90 days until earnings call
ENTA
Price
$7.06
Change
+$0.07 (+1.00%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
149.42M
3 days until earnings call
Interact to see
Advertisement

AURA vs ENTA

Header iconAURA vs ENTA Comparison
Open Charts AURA vs ENTABanner chart's image
Aura Biosciences
Price$6.73
Change+$0.18 (+2.75%)
Volume$300
Capitalization406.13M
Enanta Pharmaceuticals
Price$7.06
Change+$0.07 (+1.00%)
Volume$5.81K
Capitalization149.42M
AURA vs ENTA Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. ENTA commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and ENTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (AURA: $6.55 vs. ENTA: $6.99)
Brand notoriety: AURA and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 65% vs. ENTA: 57%
Market capitalization -- AURA: $406.13M vs. ENTA: $149.42M
AURA [@Biotechnology] is valued at $406.13M. ENTA’s [@Biotechnology] market capitalization is $149.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while ENTA’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 4 bearish.
  • ENTA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AURA is a better buy in the short-term than ENTA.

Price Growth

AURA (@Biotechnology) experienced а -4.93% price change this week, while ENTA (@Biotechnology) price change was -7.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.30%. For the same industry, the average monthly price growth was +6.68%, and the average quarterly price growth was +12.98%.

Reported Earning Dates

AURA is expected to report earnings on Nov 06, 2025.

ENTA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+0.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($406M) has a higher market cap than ENTA($149M). ENTA YTD gains are higher at: 21.565 vs. AURA (-20.316). ENTA has higher annual earnings (EBITDA): -87.12M vs. AURA (-101.63M). ENTA has more cash in the bank: 193M vs. AURA (128M). AURA has less debt than ENTA: AURA (18.4M) vs ENTA (58.7M). ENTA has higher revenues than AURA: ENTA (64.5M) vs AURA (0).
AURAENTAAURA / ENTA
Capitalization406M149M272%
EBITDA-101.63M-87.12M117%
Gain YTD-20.31621.565-94%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash128M193M66%
Total Debt18.4M58.7M31%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAENTA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 11 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHDRF502.87N/A
N/A
Christian Dior S.E.
OONEF0.32N/A
N/A
01 Communique Lab Inc.
ERNXY32.43N/A
N/A
Euronext NV
SPXXF7.78N/A
N/A
Sparebanken Nord Norge
OXINF25.08-1.00
-3.83%
Oxford Instruments plc

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
-1.83%
BEAM - ENTA
40%
Loosely correlated
-2.40%
ALEC - ENTA
39%
Loosely correlated
+1.40%
SCPH - ENTA
37%
Loosely correlated
-4.75%
ADCT - ENTA
35%
Loosely correlated
N/A
AURA - ENTA
35%
Loosely correlated
-1.21%
More